1. EGFR-mutant Non-small Cell Lung Cancer Accompanied by Transient Asymptomatic Pulmonary Opacities Successfully Treated with "Stop-And-Go" Osimertinib
   Keigo Kobayashi et al, 2018, Internal Medicine CrossRef
2. Molecular and Clinical Features of EGFR-TKI-Associated Lung Injury
   Tohru Ohmori et al, 2021, International Journal of Molecular Sciences CrossRef
3. Successful osimertinib rechallenge after osimertinib-induced pneumonitis in a patient with lung adenocarcinoma
   Shingo Satoh et al, 2018, Respiratory Medicine Case Reports CrossRef
4. Complete Tumor Response with Afatinib 20 mg Daily in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report
   Raffaele Giusti et al, 2017, Clinical Drug Investigation CrossRef
5. Salvage Therapy With Selpercatinib for RET-Rearranged NSCLC With Pralsetinib-Related Pneumonitis and Leptomeningeal Disease: A Case Report
   Paolo D. d'Arienzo et al, 2023, JTO Clinical and Research Reports CrossRef